High purity Olanzapine solution includes a comprehensive Certificate of Analysis and all supporting analytical data
High purity Cinacalcet Labeled d3 Hydrochloride includes a comprehensive Certificate of Analysis and all supporting analytical data
High purity 5-PPDi HCl (Indanyl-α-PBP , Indanyl-α-Pyrrolidinobutiophenone, 3',4'-trimethylene-α-Pyrrolidinobutiophenone, α-Pyrolidinobutiophenone indane analogue) includes a comprehensive Certificate of Analysis and all supporting analytical data
High purity Methadone intermediate (US DEA ACSCN 9254 C-II, 4-(Dimethylamino)-2,2-diphenylpentanenitrile, Didiavalo, Premethadone, Methadone Nitrile) solution includes a comprehensive Certificate of Analysis and all supporting analytical data
High purity Dienogest Labeled d4,13C,15N includes a comprehensive Certificate of Analysis and all supporting analytical data
High purity Norcyclobenzaprine (N-Desmethylcyclobenzaprine) HCl solution includes a comprehensive Certificate of Analysis and all supporting analytical data
High purity Ethyl-ß-D-Glucuronide Li salt (ethylglucuronide, ethyl-glucuronide) solution includes a comprehensive Certificate of Analysis and all supporting analytical data
High purity Linagliptin Labeled-d3 includes a comprehensive Certificate of Analysis and all supporting analytical data
High purity 4-Me-NEB (4-Methyl-α-ethylaminobutyrophenone, 4-Methyl-α-ethylaminobutiophenone) HCl includes a comprehensive Certificate of Analysis and all supporting analytical data
High purity Loxapine-N-Oxide Labeled d8 includes a comprehensive Certificate of Analysis and all supporting analytical data
High purity Terbinafine Hydrochloride Labeled d3 includes a comprehensive Certificate of Analysis and all supporting analytical data
High purity synthesized XLR11 (XLR-11, 5-F-UR-144, 5-fluoro UR-144, 5-FUR-144, US DEA C-I 7011) solution includes a comprehensive Certificate of Analysis and all supporting analytical data
High purity ADSB-FUB-187 includes a comprehensive Certificate of Analysis and all supporting analytical data. It was originally developed by Pfizer in 2009, being example 187 from patent WO 2009/106982.
High purity U-47700 includes a comprehensive Certificate of Analysis and all supporting analytical data
High purity N-Propylcathinone HCl (α-Propylaminopropiophenone) includes a comprehensive Certificate of Analysis and all supporting analytical data